New treatment protocol can potentially change the way P. vivax malaria is managed.
First real-world use of new protocol for P. vivax case management in Brazil – a Health Ministry and MMV collaboration
GSK’s RTS,S vaccine is an important complement to existing malaria interventions.
First-ever malaria vaccine to get WHO recommendation for roll-out
The positive Phase IIb results for the next generation antimalarial therapy support continued development of the combination